Samuel Weiss

USPTO Granted Patents = 37 (Patent Applications = 7)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 2.5

ph-index = 15

Forward Citations = 1,249(Granted Patents)

Location History:

Alberta, CA (1998 - 2007)
Calgary, CA (2000 - 2019)

Company Filing History:

19 out of 22

Stem Cell Therapeutics Inc.

patents

15 out of 19

Neuro Spheres Holdings Ltd.

patents

2 out of 493

The Governing Council of the University of Toronto

patents

4. 2 out of 134

Uti Limited Partnership

where one patent can have more than one assignee

Years Active: 1998-2019

Loading Chart...

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10377780 - Salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof (2019-08-13),

2. 9650399 - Salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof (2017-05-16),

3. 8470777 - Pregnancy-induced oligodendrocyte precursor cell proliferation regulated by prolactin (2013-06-25),

4. 8435949 - Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis (2013-05-07),

5. 8333974 - Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents (2012-12-18),

6. 8222212 - Prolactin induced increase in neural stem cell numbers (2012-07-17),

7. 8217002 - Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis (2012-07-10),

8. 8143220 - Dosing regimens for neural stem cell proliferating agents and differentiating agents for the treatment of neurological disorders (2012-03-27),

9. 7964563 - Oligodendrocyte precursor cell proliferation regulated by prolactin (2011-06-21),

10. 7943376 - Platelet derived growth factor (PDGF)-derived neurospheres define a novel class of progenitor cells (2011-05-17),

11. 7884072 - Prolactin induced increase in neural stem cell numbers (2011-02-08),

12. 7846898 - Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis (2010-12-07),

13. 7704737 - Oligodendrocyte production from multipotent neural stem cells (2010-04-27),

14. 7629169 - Methods for the production of platelet-derived growth factor-responsive neural precursor cells (2009-12-08),

15. 7604993 - Combined regulation of neural cell production (2009-10-20),

Title: Exploring the Innovations of Samuel Weiss

Introduction

Samuel Weiss, a prominent inventor based in Calgary, Canada, has made significant contributions to the field of biomedical research. With an impressive portfolio of 37 patents, Weiss is known for his pioneering work on compounds that have potential applications in cancer treatment.

Latest Patents

Weiss's latest patents revolve around salicylic acid derivatives and their pharmaceutically acceptable salts. These inventions focus on novel compounds and compositions that are aimed at inhibiting STAT3 and/or STAT5 activity. The methods developed by Weiss are particularly relevant for the treatment of cancers dependent on STAT3 or STAT5. His commitment to advancing medical science is evident in the applications and therapeutic methods described in his latest patent filings.

Career Highlights

Throughout his career, Samuel Weiss has been associated with esteemed organizations such as Stem Cell Therapeutics Inc. and Neuro Spheres Holdings Ltd. His work at these companies has been instrumental in driving research and innovation in regenerative medicine and biotechnology. Weiss’s contributions to these fields have enhanced our understanding of stem cell biology and potential therapeutic avenues.

Collaborations

Weiss has collaborated with notable individuals in his field, most prominently with Brent A. Reynolds and Christopher Gregg. These collaborations have potentially enriched his research and expanded the reach of his innovations, showcasing the importance of teamwork in advancing scientific progress.

Conclusion

In conclusion, Samuel Weiss stands out as a notable inventor whose work has the potential to change the landscape of cancer treatment. His numerous patents reflect a deep commitment to innovation and medical research, making him a key figure in the ongoing fight against cancer. As the landscape of biomedical research continues to evolve, Weiss's contributions will likely remain influential in shaping future therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.